Intravascular Stem Cell Bioreactor for Prevention of Adverse Remodeling After Myocardial Infarction

Overview of attention for article published in Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease, July 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 2 news outlets
twitter: 4 X users

facebook: 1 Facebook page

Readers on

mendeley: 22 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 72,322 followers.

We actually have IP on a similar concept...implantation of a "bioreactor" in vivo...to generate in real time trophic factors very cool this is why i love reading science...when people do what you prophesized https://t.co/kHVrckvd1V

RT @JAHA_AHA: Allogeneic MSCs housed in an intravascular bioreactor (IBR) can prevent adverse remodelling after #MI https://t.co/zdw3JeIrpE…

Allogeneic MSCs housed in an intravascular bioreactor (IBR) can prevent adverse remodelling after #MI https://t.co/zdw3JeIrpE #AHAJournals https://t.co/r2sQ0Zwi4q

Intravascular Stem Cell Bioreactor for Prevention of Adverse Remodeling After Myocardial Infarction. https://t.co/ZfkPngppvm

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.